Amlodipine/Losartan/Hydrochlorothiazide/Simvastatin

氨氯地平/氯沙坦钾/氢氯噻嗪/辛伐他汀

Report date: 2022/03/08 16:45:15

Base Information

Drug NameAmlodipine/Losartan/Hydrochlorothiazide/Simvastatin

Drug Alias Name辛伐他汀/氨氯地平/氯沙坦钾/氢氯噻嗪Simvastatin/Amlodipine/Losartan/Hydrochlorothiazide氯沙坦钾/氢氯噻嗪/辛伐他汀/氨氯地平Losartan/Hydrochlorothiazide/Simvastatin/AmlodipineHydrochlorothiazide/Simvastatin/Amlodipine/Losartan +[6]

ClassificationSmall molecules

Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersHMG-CoA reductase inhibitors +[4]

TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1Voltage-gated calcium channel +[4]

Therapy Area/IndicationsMyocardial InfarctionStroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Hydrochlorothiazide Losartan Potassium Amlodipine Besylate

Global Highest StatusDiscontinued (Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of London

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of London

Active IndicationsN/A

Inactive IndicationsMyocardial InfarctionStroke

Other Information

ATC CodeN/A